Loading…
Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs
The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atrop...
Saved in:
Published in: | Neuropharmacology 2005-09, Vol.49 (3), p.293-299 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613 |
---|---|
cites | |
container_end_page | 299 |
container_issue | 3 |
container_start_page | 293 |
container_title | Neuropharmacology |
container_volume | 49 |
creator | Enginar, Nurhan Nurten, Asiye Yamantürk Çelik, Pınar Açıkmeşe, Barış |
description | The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs. |
doi_str_mv | 10.1016/j.neuropharm.2005.01.032 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17457594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390805001474</els_id><sourcerecordid>17457594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</originalsourceid><addsrcrecordid>eNqFkcFu1DAURS0Eaqelv4C8YkXCc-IkNjuoaEGqxAJYW479XDwk9mAnI_Uj-GfcTqQuWdl69z5f-R5CKIOaAevf7-uAa4qHXzrNdQPQ1cBqaJsXZMfE0FYD9Pwl2QE0omoliHNykfMeALhg4oycs04yyaDZkb_fTTzESc8-YOWDXQ1aamI4rlP2MWTqA3U6L2U6e4NUuwUTdTHaoiz6N36g6ByaJdPo6P20mphxk95RHRY_r9no5IM3VJvFH_3yUOb2SduCypXatN7n1-SV01PGq-28JD9vPv-4_lLdfbv9ev3xrjIc2qWyQrYIpQnkHJ2Gbmz6dpC9to0dxr7rpZGD0E6MvJMWBsFazcVoR2v6Uh9rL8nb07uHFP-smBc1-2xwmnTAuGbFBt4NneTFKE5Gk2LOCZ06JD_r9KAYqEcUaq-eUahHFAqYKijK6pstYx1ntM-LW_fF8OlkwPLTo8eksvEYCgCfSqHKRv__lH9nbqN3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17457594</pqid></control><display><type>article</type><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><source>Elsevier</source><creator>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</creator><creatorcontrib>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</creatorcontrib><description>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2005.01.032</identifier><identifier>PMID: 15919102</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Anticonvulsants ; Anticonvulsants - administration & dosage ; Anticonvulsants - pharmacology ; Antimuscarinic activity ; Biperiden - pharmacology ; Eating - physiology ; Fasting ; Food intake ; Glucose - administration & dosage ; Glucose - pharmacology ; Glucose intake ; Hypoglycemia - chemically induced ; Hypoglycemia - psychology ; Male ; Mice ; Mice, Inbred BALB C ; Muscarinic Antagonists - pharmacology ; Myoclonus - chemically induced ; Myoclonus - physiopathology ; Scopolamine Hydrobromide - pharmacology ; Scopolamine-induced convulsions ; Seizures - chemically induced</subject><ispartof>Neuropharmacology, 2005-09, Vol.49 (3), p.293-299</ispartof><rights>2005 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15919102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Enginar, Nurhan</creatorcontrib><creatorcontrib>Nurten, Asiye</creatorcontrib><creatorcontrib>Yamantürk Çelik, Pınar</creatorcontrib><creatorcontrib>Açıkmeşe, Barış</creatorcontrib><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</description><subject>Animals</subject><subject>Anticonvulsants</subject><subject>Anticonvulsants - administration & dosage</subject><subject>Anticonvulsants - pharmacology</subject><subject>Antimuscarinic activity</subject><subject>Biperiden - pharmacology</subject><subject>Eating - physiology</subject><subject>Fasting</subject><subject>Food intake</subject><subject>Glucose - administration & dosage</subject><subject>Glucose - pharmacology</subject><subject>Glucose intake</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemia - psychology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Muscarinic Antagonists - pharmacology</subject><subject>Myoclonus - chemically induced</subject><subject>Myoclonus - physiopathology</subject><subject>Scopolamine Hydrobromide - pharmacology</subject><subject>Scopolamine-induced convulsions</subject><subject>Seizures - chemically induced</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAURS0Eaqelv4C8YkXCc-IkNjuoaEGqxAJYW479XDwk9mAnI_Uj-GfcTqQuWdl69z5f-R5CKIOaAevf7-uAa4qHXzrNdQPQ1cBqaJsXZMfE0FYD9Pwl2QE0omoliHNykfMeALhg4oycs04yyaDZkb_fTTzESc8-YOWDXQ1aamI4rlP2MWTqA3U6L2U6e4NUuwUTdTHaoiz6N36g6ByaJdPo6P20mphxk95RHRY_r9no5IM3VJvFH_3yUOb2SduCypXatN7n1-SV01PGq-28JD9vPv-4_lLdfbv9ev3xrjIc2qWyQrYIpQnkHJ2Gbmz6dpC9to0dxr7rpZGD0E6MvJMWBsFazcVoR2v6Uh9rL8nb07uHFP-smBc1-2xwmnTAuGbFBt4NneTFKE5Gk2LOCZ06JD_r9KAYqEcUaq-eUahHFAqYKijK6pstYx1ntM-LW_fF8OlkwPLTo8eksvEYCgCfSqHKRv__lH9nbqN3</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Enginar, Nurhan</creator><creator>Nurten, Asiye</creator><creator>Yamantürk Çelik, Pınar</creator><creator>Açıkmeşe, Barış</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20050901</creationdate><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><author>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Anticonvulsants</topic><topic>Anticonvulsants - administration & dosage</topic><topic>Anticonvulsants - pharmacology</topic><topic>Antimuscarinic activity</topic><topic>Biperiden - pharmacology</topic><topic>Eating - physiology</topic><topic>Fasting</topic><topic>Food intake</topic><topic>Glucose - administration & dosage</topic><topic>Glucose - pharmacology</topic><topic>Glucose intake</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemia - psychology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Muscarinic Antagonists - pharmacology</topic><topic>Myoclonus - chemically induced</topic><topic>Myoclonus - physiopathology</topic><topic>Scopolamine Hydrobromide - pharmacology</topic><topic>Scopolamine-induced convulsions</topic><topic>Seizures - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Enginar, Nurhan</creatorcontrib><creatorcontrib>Nurten, Asiye</creatorcontrib><creatorcontrib>Yamantürk Çelik, Pınar</creatorcontrib><creatorcontrib>Açıkmeşe, Barış</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Enginar, Nurhan</au><au>Nurten, Asiye</au><au>Yamantürk Çelik, Pınar</au><au>Açıkmeşe, Barış</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>49</volume><issue>3</issue><spage>293</spage><epage>299</epage><pages>293-299</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15919102</pmid><doi>10.1016/j.neuropharm.2005.01.032</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2005-09, Vol.49 (3), p.293-299 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_proquest_miscellaneous_17457594 |
source | Elsevier |
subjects | Animals Anticonvulsants Anticonvulsants - administration & dosage Anticonvulsants - pharmacology Antimuscarinic activity Biperiden - pharmacology Eating - physiology Fasting Food intake Glucose - administration & dosage Glucose - pharmacology Glucose intake Hypoglycemia - chemically induced Hypoglycemia - psychology Male Mice Mice, Inbred BALB C Muscarinic Antagonists - pharmacology Myoclonus - chemically induced Myoclonus - physiopathology Scopolamine Hydrobromide - pharmacology Scopolamine-induced convulsions Seizures - chemically induced |
title | Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A15%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Scopolamine-induced%20convulsions%20in%20fasted%20mice%20after%20food%20intake:%20effects%20of%20glucose%20intake,%20antimuscarinic%20activity%20and%20anticonvulsant%20drugs&rft.jtitle=Neuropharmacology&rft.au=Enginar,%20Nurhan&rft.date=2005-09-01&rft.volume=49&rft.issue=3&rft.spage=293&rft.epage=299&rft.pages=293-299&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2005.01.032&rft_dat=%3Cproquest_cross%3E17457594%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17457594&rft_id=info:pmid/15919102&rfr_iscdi=true |